Human iPSC-based modeling of late-onset disease via progerin-induced aging

Miller, Justine D., Ganat, Yosif M., Kishinevsky, Sarah, Bowman, Robert L., Liu, Becky, Tu, Edmund Y., Mandal, Pankaj K., Vera, Elsa +9 more·2013·Cell stem cell

Cited by (783)

Items 201–300 of 783

  1. Combating neurodegenerative disease with chemical probes and model systems
    Priyanka S. Narayan, Sepehr Ehsani, Susan Lee Lindquist · 2014 · Nature Chemical Biology
  2. Organoid factory: The recent role of the human induced pluripotent stem cells (hiPSCs) in precision medicine
    Novelli, Giuseppe, Spitalieri, Paola, Murdocca, Michela, Centanini, Eleonora, Sangiuolo, Federica · 2023 · Frontiers in Cell and Developmental Biology
  3. Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson’s disease
    Janelle Drouin‐Ouellet, Emilie M. Legault, Fredrik Nilsson, Karolina Pircs, Julie Bouquety, Florence Petit, Shelby Shrigley, Marcella Birtele, Maria Pereira, Petter Storm et al. · 2022 · Stem Cell Reports
  4. Functional bioengineered models of the central nervous system
    Nicolas Rouleau, Nirosha J. Murugan, David Lee Kaplan · 2023 · Nature Reviews Bioengineering
  5. Transcriptional comparison of human induced and primary midbrain dopaminergic neurons
    Ninuo Xia, Pengbo Zhang, Fang Fang, Zhengyuan Wang, Megan Rothstein, Benjamin Angulo, Rosaria Chiang, James Taylor, Renee A. Reijo Pera · 2016 · Scientific Reports
  6. DNA replication timing alterations identify common markers between distinct progeroid diseases
    Juan Carlos Rivera‐Mulia, Romain Desprat, Claudia Trevilla‐García, Daniela Cornacchia, Hélène Schwerer, Takayo Sasaki, Jiao Sima, Tyler Fells, Lorenz Studer, Jean-Marc Lemaı̂tre et al. · 2017 · Proceedings of the National Academy of Sciences
  7. Human stem cell models to study host–virus interactions in the central nervous system
    Oliver Harschnitz, Lorenz Studer · 2021 · Nature reviews. Immunology
  8. Utility of Induced Pluripotent Stem Cells for the Study and Treatment of Genetic Diseases: Focus on Childhood Neurological Disorders
    Serena Barral, Manju A. Kurian · 2016 · Frontiers in Molecular Neuroscience
  9. Paving the Way Toward Complex Blood-Brain Barrier Models Using Pluripotent Stem Cells
    Karin Lauschke, Lise Frederiksen, Vanessa Jane Hall · 2017 · Stem Cells and Development
  10. From cell lines to pluripotent stem cells for modelling Parkinson's Disease
    Elena Silvia Ferrari, Antonella Cardinale, Barbara Picconi, Fabrizio Gardoni · 2020 · Journal of Neuroscience Methods
  11. Maternal immune activation primes deficiencies in adult hippocampal neurogenesis
    A. Couch, Thomas Berger, B. Hanger, R. Matuleviciute, D. Srivastava, S. Thuret, A. Vernon · 2021 · Brain, behavior, and immunity
  12. When rejuvenation is a problem: challenges of modeling late-onset neurodegenerative disease
    Elsa Vera, Lorenz Studer · 2015 · Development
  13. Modeling rare diseases with induced pluripotent stem cell technology
    Ruthellen H. Anderson, Kevin R. Francis · 2018 · Molecular and Cellular Probes
  14. The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks
    Nolwenn Briand, Anne-Claire Guénantin, Dorota Jeziorowska, Akshay Shah, Matthieu Mantecon, Émilie Capel, Marie Garcia, Anja R. Oldenburg, Jonas Paulsen, Jean‐Sébastien Hulot et al. · 2018 · Human Molecular Genetics
  15. Mitochondrial dysfunction and oxidative stress in induced pluripotent stem cell models of Parkinson's disease
    Anindita Bose, M. Flint Beal · 2018 · European Journal of Neuroscience
  16. LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1
    Garikoitz Azkona, Rakel López de Maturana, Patricia del Río, Amaya Sousa, Nerea Vázquez, Amaia Zubiarrain, Daniel Jiménez-Blasco, Juan Pedro Bolaños, Blas Morales, Georg W. J. Auburger et al. · 2016 · Molecular Neurobiology
  17. Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases
    Sandy S. C. Hung, Shahnaz Khan, Camden Yeung-Wah Lo, Alex William Hewitt, Raymond C.B. Wong · 2017 · Pharmacology & Therapeutics
  18. Nanotopography-responsive myotube alignment and orientation as a sensitive phenotypic biomarker for Duchenne Muscular Dystrophy
    Bin Xu, Alessandro Magli, Yoska Anugrah, Steven J. Koester, Rita C. R. Perlingeiro, Wei Shen · 2018 · Biomaterials
  19. Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer’s disease (AD) risk
    Sreedevi Raman, Nicholas Brookhouser, David A. Brafman · 2020 · Neurobiology of Disease
  20. Patient-Derived Midbrain Organoids to Explore the Molecular Basis of Parkinson's Disease
    Benjamin Galet, Hélène Cheval, Philippe Ravassard · 2020 · Frontiers in Neurology
  21. Investigating the Structure of Neurotoxic Protein Aggregates Inside Cells
    Felix J.B. Bäuerlein, Rubén Fernández‐Busnadiego, Wolfgang P. Baumeister · 2020 · Trends in Cell Biology
  22. Long-term culture of SH-SY5Y neuroblastoma cells in the absence of neurotrophins: A novel model of neuronal ageing
    Lisa Strother, Gareth Brian Miles, Alison Holiday, Ying Cheng, Gayle Helane Doherty · 2021 · Journal of Neuroscience Methods
  23. Restoration of neuronal progenitors by partial reprogramming in the aged neurogenic niche
    Lucy Xu, Julliana Ramirez-Matias, Max Hauptschein, Eric Sun, Judith C. Lunger, Matthew T. Buckley, Anne Brunet · 2024 · Nature Aging
  24. Recent technological updates and clinical applications of induced pluripotent stem cells
    Sebastian Diecke, Seung Min Jung, Jaecheol Lee, Ji Hyeon Ju · 2014 · The Korean Journal of Internal Medicine
  25. Induced pluripotent stem cell technology for modelling and therapy of cerebellar ataxia
    Lauren M. Watson, Maggie M. K. Wong, Esther B. E. Becker · 2015 · Open Biology
  26. Stem Cells in the Nervous System
    Angel R. Maldonado‐Soto, Derek H. Oakley, Hynek Wichterle, Joel M. Stein, Fiona K. Doetsch, Christopher E. Henderson · 2014 · American Journal of Physical Medicine & Rehabilitation
  27. ZSCAN10 expression corrects the genomic instability of iPSCs from aged donors
    Maria Skamagki, Cristina Correia, Percy Luk Yeung, Timour Baslan, Samuel J. Beck, Cheng Zhang, Christian A Ross, Lam Dang, Zhong Liu, Simona Giunta et al. · 2017 · Nature Cell Biology
  28. Concise Review: The Cellular Conspiracy of Amyotrophic Lateral Sclerosis
    Andrea Serio, Rickie Patani · 2017 · Stem Cells
  29. Mechanistic Insights Into MicroRNA-Induced Neuronal Reprogramming of Human Adult Fibroblasts
    Ya-Lin Lu, Andrew S.J. Yoo · 2018 · Frontiers in Neuroscience
  30. Modeling Parkinson’s Disease Using Patient-specific Induced Pluripotent Stem Cells
    Hong Li, Houbo Jiang, Boyang Zhang, Jian Feng · 2018 · Journal of Parkinson s Disease
  31. Modeling Alzheimer’s Disease by Induced Pluripotent Stem Cells Carrying APP D678H Mutation
    Kuo‐Hsuan Chang, Guey‐Jen Lee‐Chen, Ching-Chang Huang, Jia-Li Lin, Yi-Jing Chen, Pei-Chi Wei, Yen‐Shi Lo, Chin-Fa Yao, Ming‐Wei Kuo, Chiung‐Mei Chen · 2018 · Molecular Neurobiology
  32. Mitochondrial dysfunction in neurodegenerative diseases: A focus on iPSC-derived neuronal models
    Marina Trombetta-Lima, Angélica María Sabogal-Guáqueta, Amalia M. Dolga · 2021 · Cell Calcium
  33. Cell-Based Screening: Extracting Meaning from Complex Data
    Steven Finkbeiner, Mitchell H. Frumkin, P. Kassner · 2015 · Neuron
  34. Modeling Huntington׳s disease with patient-derived neurons
    Virginia B. Mattis, Clive N. Svendsen · 2015 · Brain Research
  35. Translational potential of human brain organoids
    Alfred Xuyang Sun, Huck‐Hui Ng, Eng‐King Tan · 2018 · Annals of Clinical and Translational Neurology
  36. Recapitulating developmental mechanisms for retinal regeneration
    Iqbal Ahmad, Pooja Teotia, Helen E. Erickson, Xiaohuan Xia · 2019 · Progress in Retinal and Eye Research
  37. Organoid and pluripotent stem cells in Parkinson’s disease modeling: an expert view on their value to drug discovery
    Nicolas Marotta, Soojin Kim, Dimitri Krainc · 2020 · Expert Opinion on Drug Discovery
  38. Long Term Gene Expression in Human Induced Pluripotent Stem Cells and Cerebral Organoids to Model a Neurodegenerative Disease
    Férid Nassor, Rafika Jarray, Denis S.F. Biard, Auriane Maïza, Dulce Papy-García, Serena Pavoni, Jean‐Philippe Deslys, Frank Yates · 2020 · Frontiers in Cellular Neuroscience
  39. Human iPSC application in Alzheimer’s disease and tau-related neurodegenerative diseases
    TCW, Julia · 2019 · Neuroscience Letters
  40. β2 integrins impose a mechanical checkpoint on macrophage phagocytosis
    Alexander H. Settle, Benjamin Y. Winer, Miguel de Jesus, Lauren Seeman, Zhaoquan Wang, Eric Chan, Yevgeniy Romin, Zhuoning Li, Matthew M. Miele, Ronald C. Hendrickson et al. · 2024 · Nature Communications
  41. Human Embryonic Stem Cells: A Model for the Study of Neural Development and Neurological Diseases
    Piya Prajumwongs, Oratai Weeranantanapan, Thiranut Jaroonwitchawan, Parinya Noisa · 2016 · Stem Cells International
  42. Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases
    Xinwen Zhang, Di Hu, Yutong Shang, Xin Qi · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  43. Comprehensive Perspectives on Experimental Models for Parkinson’s Disease
    Minjing Ke, Cheong‐Meng Chong, Qi Zhu, Ke Zhang, Cui-Zan Cai, Jiahong Lu, Dajiang Qin, Huanxing Su · 2021 · Aging and Disease
  44. Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia
    Katrina Albert, Jonna Niskanen, Sara Kälvälä, Šárka Lehtonen · 2021 · International Journal of Molecular Sciences
  45. Neuromuscular Development and Disease: Learning From in vitro and in vivo Models
    Zachary Fralish, Ethan M. Lotz, Taylor Chavez, Alastair Khodabukus, Nenad Bursac · 2021 · Frontiers in Cell and Developmental Biology
  46. Harnessing cerebral organoids for Alzheimer's disease research
    Adele Bubnys, Li‐Huei Tsai · 2021 · Current Opinion in Neurobiology
  47. Retinal Organoids and Retinal Prostheses: An Overview
    Alessandro Bellapianta, Ana Cetkovic, Matthias Bolz, Ahmad Salti · 2022 · International Journal of Molecular Sciences
  48. Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions
    Isabel Lam, Alain Ndayisaba, Amanda J. Lewis, YuHong Fu, Giselle T. Sagredo, Anastasia Kuzkina, Ludovica Zaccagnini, Meral Celikag, Jackson Sandoe, Ricardo L. Sanz et al. · 2024 · Neuron
  49. Induced Pluripotent Stem Cell Models to Enable In Vitro Models for Screening in the Central Nervous System
    Joshua G. Hunsberger, Anastasia G. Efthymiou, Nasir Malik, Mamta Behl, Ivy Mead, Xianmin Zeng, Anton M. Simeonov, Mahendra S. Rao · 2015 · Stem Cells and Development
  50. Multi-level characterization of balanced inhibitory-excitatory cortical neuron network derived from human pluripotent stem cells
    Aishwarya G. Nadadhur, Javier Emperador-Melero, Marieke Meijer, Désireé Schut, Gerbren Jacobs, Ka Wan Li, J. J. Johannes Hjorth, Rhiannon M. Meredith, Ruud F. G. Toonen, Ronald E. van Kesteren et al. · 2017 · PLoS ONE
  51. iPS cells in the study of PD molecular pathogenesis
    Melanie M. Cobb, Abinaya Ravisankar, Gaia Skibinski, Steven M. Finkbeiner · 2017 · Cell and Tissue Research
  52. Modeling cancer using patient-derived induced pluripotent stem cells to understand development of childhood malignancies
    Ana Marín Navarro, Evelyn Susanto, Anna Falk, Margareta Wilhelm · 2018 · Cell Death Discovery
  53. Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling
    Daniela Gois Beghini, Taís Hanae Kasai-Brunswick, Andrea Henriques‐Pons · 2024 · International Journal of Molecular Sciences
  54. Cellular reprogramming for understanding and treating human disease
    Riya R. Kanherkar, Naina Bhatia‐Dey, Evgeny Makarev, Antonei Benjamin Csoka · 2014 · Frontiers in Cell and Developmental Biology
  55. Induced Pluripotent Stem Cells in Huntington’s Disease Research: Progress and Opportunity
    Adelaide R. Tousley, Kimberly B. Kegel-Gleason · 2016 · Journal of Huntington s Disease
  56. Aged induced pluripotent stem cell (iPSCs) as a new cellular model for studying premature aging
    Stefania Petrini, Rossella Borghi, Valentina Doria, Fabrizia Restaldi, Sandra Moreno, Antonio Novelli, Enrico Bertini, Claudia Compagnucci · 2017 · Aging
  57. Modelling Sporadic Alzheimer’s Disease Using Induced Pluripotent Stem Cells
    Helen A. Rowland, Nigel M. Hooper, Katherine A. B. Kellett · 2018 · Neurochemical Research
  58. Modelling Parkinson’s Disease: iPSCs towards Better Understanding of Human Pathology
    Sahar Avazzadeh, Jara M. Baena-Montes, Cameron Noah Keighron, Yajaira Feller Sánchez, Leo R. Quinlan · 2021 · Brain Sciences
  59. Lessons from inducible pluripotent stem cell models on neuronal senescence in aging and neurodegeneration
    Isabelle R. de Luzy, Michael K. Lee, William C. Mobley, Lorenz Studer · 2024 · Nature Aging
  60. Strategies for modeling aging and age-related diseases
    D. Jothi, Linda Anna Michelle Kulka · 2024 · npj Aging
  61. Using Patient-Derived Induced Pluripotent Stem Cells to Model and Treat Epilepsies
    Xixi Du, Jack M. Parent · 2015 · Current Neurology and Neuroscience Reports
  62. Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures
    Jiun‐I Lai, Daniel C. Nachun, Lina Petrosyan, Benjamin T. Throesch, Erica Campau, Fuying Gao, Kristin K. Baldwin, Giovanni Coppola, Joel M. Gottesfeld, Elisabetta Soragni · 2018 · Journal of Biological Chemistry
  63. Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders
    Aurélie de Rus Jacquet, Hélèna L. Denis, Francesca Cicchetti, Melanie Alpaugh · 2021 · Molecular Psychiatry
  64. Age and sex differentially shape brain networks in Parkinson's disease
    Zhichun Chen, Bin Wu, Guanglu Li, Liche Zhou, Lina Zhang, Jun Liu · 2023 · CNS Neuroscience & Therapeutics
  65. Cellular senescence and neurodegeneration
    Kristopher Holloway, Kashfia Neherin, Kha Uyen Dam, Hong Zhang · 2023 · Human Genetics
  66. Maturing differentiated human pluripotent stem cells in vitro: methods and challenges.
    D. Ottaviani, M. ter Huurne, D. Elliott, M. Bellin, C. Mummery · 2023 · Development
  67. Neural cell state shifts and fate loss in ageing and age-related diseases
    Larissa Traxler, Raffaella Lucciola, Joseph R. Herdy, Jeffrey R. Jones, Jérôme Mertens, Fred H. Gage · 2023 · Nature Reviews Neurology
  68. Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases
    Lei Cao, Lan Tan, Teng Jiang, Xi‐Chen Zhu, Jin‐Tai Yu · 2014 · Molecular Neurobiology
  69. The pathogenic LRRK2 R1441C mutation induces specific deficits modeling the prodromal phase of Parkinson's disease in the mouse
    Florian Giesert, Lisa Glasl, Annemarie Zimprich, Luise Ernst, Giovanni Piccoli, Constantin Stautner, Julia Zerle, Sabine M. Hölter, Daniela M. Vogt Weisenhorn, Wolfgang Wurst · 2017 · Neurobiology of Disease
  70. The application of in vitro ‐derived human neurons in neurodegenerative disease modeling
    Gary X. D’Souza, Shannon E. Rose, Allison Knupp, Daniel A. Nicholson, Christopher Dirk Keene, Jessica E. Young · 2020 · Journal of Neuroscience Research
  71. Telomere shortening induces aging-associated phenotypes in hiPSC-derived neurons and astrocytes
    Jasmine Harley, Munirah Mohamad Santosa, Chong Yi Ng, Oleg V. Grinchuk, Jin‐Hui Hor, Yajing Liang, Valerie Jing Wen Lim, Wee‐Wei Tee, Derrick Sek Tong Ong, Shi‐Yan Ng · 2023 · Biogerontology
  72. Neural Differentiation in the Third Dimension: Generating a Human Midbrain
    Rebecca M. Marton, Sergiu P. Pașca · 2016 · Cell stem cell
  73. Increased nicotine response in iPSC-derived human neurons carrying the CHRNA5 N398 allele
    Eileen N. Oni, Apoorva Halikere, Guohui Li, Alana J. Toro-Ramos, Mavis R. Swerdel, Jessica L. Verpeut, Jennifer C. Moore, Nicholas T. Bello, Laura Jean Bierut, Alison Goate et al. · 2016 · Scientific Reports
  74. Generating CNS organoids from human induced pluripotent stem cells for modeling neurological disorders.
    Andrew T. Brawner, Ranjie Xu, Dingfeng Liu, Peng Jiang · 2017 · Europe PMC (PubMed Central)
  75. Protein sequestration at the nuclear periphery as a potential regulatory mechanism in premature aging
    Leonid Serebryannyy, Tom Misteli · 2017 · The Journal of Cell Biology
  76. Mitochondrion-Dependent Cell Death in TDP-43 Proteinopathies
    Chantal Blanche Lucini, Ralf J. Braun · 2021 · Biomedicines
  77. Engineered neural circuits for modeling brain physiology and neuropathology
    Seokyoung Bang, Kyeong Seob Hwang, Sohyeon Jeong, Il‐Joo Cho, Nakwon Choi, Jongbaeg Kim, Hong Nam Kim · 2021 · Acta Biomaterialia
  78. Novel Approaches Used to Examine and Control Neurogenesis in Parkinson′s Disease
    Alla B. Salmina, Капкаева Марина Рафаилевна, Anna S. Vetchinova, Sergey Nikolaevich Illarioshkin · 2021 · International Journal of Molecular Sciences
  79. Uncovering specificity of endogenous TAU aggregation in a human iPSC-neuron TAU seeding model
    Justine D. Manos, Christina N Preiss, Nandini Venkat, Joseph A. Tamm, Peter Reinhardt, Taekyung Kwon, Jessica Wu, Allison D. Winter, Thomas Robert Jahn, Kiran Yanamandra et al. · 2021 · iScience
  80. Modeling motor neuron disease: the matter of time
    Arbab, Mandana, Baars, Susanne, Geijsen, Niels · 2014 · Trends in Neurosciences
  81. Induced pluripotent stem cell-derived and directly reprogrammed neurons to study neurodegenerative diseases: The impact of aging signatures
    Simona Aversano, Carmen Caiazza, Massimiliano Caiazzo · 2022 · Frontiers in Aging Neuroscience
  82. Modeling physiological and pathological human neurogenesis in the dish
    Vania Broccoli, Serena Gea Giannelli, Pietro Giuseppe Mazzara · 2014 · Frontiers in Neuroscience
  83. Modeling Parkinson’s Disease Using Induced Pluripotent Stem Cells
    Xinchao Hu, Chengyuan Mao, Liyuan Fan, Haiyang Luo, Zhengwei Hu, Shuo Zhang, Zhihua Yang, Huimin Zheng, Huifang Sun, Yu Fan et al. · 2020 · Stem Cells International
  84. Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling
    de Leeuw, Sherida, Tackenberg, Christian · 2019 · Translational Neurodegeneration
  85. Evaluating Cell Processes, Quality, and Biomarkers in Pluripotent Stem Cells Using Video Bioinformatics
    Atena Zahedi, Vincent On, Sabrina Chia-Chin Lin, Brett C. Bays, Esther E. Omaiye, Bir Bhanu, Prue Talbot · 2016 · PLoS ONE
  86. The Influence of the Val66Met Polymorphism of Brain-Derived Neurotrophic Factor on Neurological Function after Traumatic Brain Injury
    John D. Finan, Shreya Udani, Vimal A. Patel, Julian E. Bailes · 2018 · Journal of Alzheimer s Disease
  87. Preparation and Co‐Culture of iPSC‐Derived Dopaminergic Neurons and Astrocytes
    Aurélie de Rus Jacquet · 2019 · Current Protocols in Cell Biology
  88. Phosphorylation-driven epichaperome assembly is a regulator of cellular adaptability and proliferation
    Tanaya Roychowdhury, Seth W. McNutt, Chiranjeevi Pasala, Hieu Thi Nguyen, Daniel T. Thornton, Sahil Sharma, Luke Botticelli, Chander Singh Digwal, Suhasini Joshi, Nan Yang et al. · 2024 · Nature Communications
  89. Induced pluripotent stem cell models of lysosomal storage disorders
    Daniel K. Borger, B. McMahon, T. R. Roshan Lal, Jenny Serra-Vinardell, Elma Aflaki, E. Sidransky · 2017 · Disease Models & Mechanisms
  90. Contribution of induced pluripotent stem cell technologies to the understanding of cellular phenotypes in schizophrenia
    Shabeesh Balan, Manabu Toyoshima, Takeo Yoshikawa · 2018 · Neurobiology of Disease
  91. Stem cell models of human synapse development and degeneration
    Emily S. Wilson, Karen Litwa · 2018 · Molecular Biology of the Cell
  92. Investigation of the input-output relationship of engineered neural networks using high-density microelectrode arrays
    Jens Duru, Benedikt Maurer, Ciara Giles Doran, Robert Jelitto, Joël Küchler, Stephan J. Ihle, Tobias Ruff, Robert John, Barbara Genocchi, János Vörös · 2023 · Biosensors and Bioelectronics
  93. Human midbrain organoids: a powerful tool for advanced Parkinson’s disease modeling and therapy exploration
    Xin Cui, Xinwei Li, Huimin Zheng, Yun Su, Shuyu Zhang, Mengjie Li, Xiaoyan Hao, Shuo Zhang, Zhengwei Hu, Zongping Xia et al. · 2024 · npj Parkinson s Disease
  94. Epigenetic Modulation of Human Induced Pluripotent Stem Cell Differentiation to Oligodendrocytes
    Panagiotis Douvaras, Tomasz Rusielewicz, Kwi Kim, Jeffery D. Haines, Patrizia Casaccia, Valentina Fossati · 2016 · International Journal of Molecular Sciences
  95. Blood Derived Induced Pluripotent Stem Cells (iPSCs): Benefits, Challenges and the Road Ahead
    Jimmy A. El Hokayem, Holly N. Cukier, Derek Michael Dykxhoorn · 2016 · Journal of Alzheimer’s Disease & Parkinsonism
  96. An update on stem cell biology and engineering for brain development
    Callum Parr, Shinya Yamanaka, Hirohide Saito · 2017 · Molecular Psychiatry
  97. Physiological and pathological roles of LRRK2 in the nuclear envelope integrity
    Vered Shani, Hazem Safory, Raymonde Szargel, Ninghan Wang, Tsipora Cohen, Fatimah Abd Elghani, Haya Hamza, Mor Savyon, Inna S. Radzishevsky, Lihi Shaulov et al. · 2019 · Human Molecular Genetics
  98. Advances in Central Nervous System Organoids: A Focus on Organoid-Based Models for Motor Neuron Disease
    Renata Vieira de Sá, Marta Cañizares Luna, R. Jeroen Pasterkamp · 2021 · Tissue Engineering Part C Methods
  99. Bicistronic CACNA1A Gene Expression in Neurons Derived from Spinocerebellar Ataxia Type 6 Patient-Induced Pluripotent Stem Cells
    Carlo Bavassano, Andreas Eigentler, Ruslan I. Stanika, Gerald J. Obermair, Sylvia Boesch, Georg Dechant, Roxana Nat · 2017 · Stem Cells and Development
  100. Induced Pluripotent Stem Cells
    Chia-Yu Chang, Hsiao-Chien Ting, Ching-Ann Liu, Hong-Lin Su, Tzyy‐Wen Chiou, Horng‐Jyh Harn, Shinn‐Zong Lin · 2018 · Cell Transplantation